Skip to main content
. Author manuscript; available in PMC: 2024 Jan 21.
Published in final edited form as: J Control Release. 2022 Dec 1;353:278–288. doi: 10.1016/j.jconrel.2022.10.017

Fig. 8.

Fig. 8.

(A) Fluorescence images of harvested lung (lg), heart (h), liver (lv), kidneys (k), spleen (s), stomach and intestines (s&i), and breast tumor (tumor) from mice 168 h after tail-vein injection of Cy5.5-labeled HPMA-CHP, HPMA-SCHP, or CHP, (B) percent of signal in each organ or tumor out of total signal in organs and tumor at 168 h, with comparison between percentage in tumors between the three groups, and (C) fluorescent signal in radiant efficiency units in each organ or tumor in HPMA-CHP, HPMA-SCHP, and CHP. (Mean ± SD, N = 5, *p < 0.05, **p < 0.01, ***p < 0.001).